Cowen and Company’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Cowen and Company’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-844	Closed	-$115K	–	649
2020 Q3	$115K	Buy	+844	New	+$89.7K	0.02%	251

Cowen and Company's MYOK Position: Q4 2020 in Review

Cowen and Company sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 844 shares — an estimated $115K sold.

Cowen and Company first reported a position in MYOK in Q3 2020 and held it in 1 quarter. The position peaked at $115K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Cowen and Company reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Cowen and Company sold 844 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $115K.
Cowen and Company first reported a position in MyoKardia, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
Cowen and Company's MyoKardia, Inc. Common Stock position peaked at $115K in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Cowen and Company's 13F filing for Q4 2020, filed 8 Feb 2021.